Myles Greenberg

Myles Greenberg

Director Ejecutivo en
InCarda Therapeutics, Inc.
.
58 años
Health Technology
Consumer Services
Commercial Services

Perfil

Myles D.
Greenberg
is currently Chief Executive Officer at InCarda Therapeutics, Inc. since 2024.
He is a Director at Urgent Care Centers of New England, Inc. He is a Partner at CHL Healthcare Partners LLC since 2013 and a Venture Partner at Healthinvest Equity Partners.
Formerly, Dr. Greenberg was President, Chief Executive Officer & Director at Alucent Biomedical Inc. from 2017 to 2024.
He served as Chairman at Cantex Pharmaceuticals, Inc. and held Director positions at Oriel Therapeutics, Inc., Angiomics, Inc., Millennium Pharmacy Systems, Inc., NuVasive LLC, Dynogen Pharmaceuticals, Inc., Vertos Medical, Inc., Ivrea Pharmaceuticals, Inc., Oculir, Inc., DICOM Grid, Inc., FlowCardia, Inc., and Mevion Medical Systems, Inc. as an Independent Director.
He was Assistant Clinical Director-Emergency Department at Beth Israel Deaconess Medical Center, Inc. and Assistant Clinical Director-Emergency Medicine at Harvard Medical School.
He was Senior Principal at Pappas Capital LLC from 2000 to 2003 and Assistant Professor at UNC School of Medicine.
Education includes an MBA from Harvard Business School in 2000, a doctorate from Yale School of Medicine in 1993, and an undergraduate degree from the School of Engineering & Applied Science in 1989.

Cargos activos de Myles Greenberg

EmpresasCargoInicio
Inversor de Capital Privado 01/01/2004
Director/Miembro de la Junta -
Inversor de Capital Privado -
Director Ejecutivo 10/12/2024

Antiguos cargos conocidos de Myles Greenberg.

EmpresasCargoFin
Director Ejecutivo 02/11/2024
Director/Miembro de la Junta 23/10/2008
Corporate Officer/Principal 31/12/2003
Director/Miembro de la Junta -
NUVASIVE, INC. Director/Miembro de la Junta -
Ver el detalle de la experiencia de Myles Greenberg.

Formación de Myles Greenberg.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

98

Relaciones de 1er grado

24

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas24

Health Technology

Angiomics, Inc.

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Finance

Finance

Health Services

Health Technology

Consumer Services

Commercial Services

Health Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Finance

Commercial Services